Home/Filings/4/0001737287-23-000004
4//SEC Filing

Roberts Zachary 4

Accession 0001737287-23-000004

CIK 0001737287other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 5:02 PM ET

Size

6.8 KB

Accession

0001737287-23-000004

Insider Transaction Report

Form 4
Period: 2023-01-20
Roberts Zachary
EVP of R&D
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-20+873,015873,015 total
    Exercise: $6.55Exp: 2033-01-20Common Stock (873,015 underlying)
  • Award

    Common Stock

    2023-01-20+251,908251,908 total
Footnotes (1)
  • [F1]25% of the shares subject to the stock option shall vest on January 03, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001851044

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:02 PM ET
Size
6.8 KB